tiprankstipranks
Advertisement
Advertisement
Serina Therapeutics Advances SER-252 Parkinson’s Trial, Marking a Key Early Milestone for Investors
PremiumCompany AnnouncementsSerina Therapeutics Advances SER-252 Parkinson’s Trial, Marking a Key Early Milestone for Investors
2M ago
Serina Therapeutics doses first patient in SER-252 trial
Premium
The Fly
Serina Therapeutics doses first patient in SER-252 trial
2M ago
Serina Therapeutics says first patient enrolled in Phase 1b trial of SER-252
Premium
The Fly
Serina Therapeutics says first patient enrolled in Phase 1b trial of SER-252
3M ago
Serina Therapeutics receives NYSE deficiency notice on equity standards
PremiumThe FlySerina Therapeutics receives NYSE deficiency notice on equity standards
4M ago
Serina Therapeutics Faces NYSE American Compliance Deficiency Notice
Premium
Company Announcements
Serina Therapeutics Faces NYSE American Compliance Deficiency Notice
4M ago
Serina Therapeutics submits complete response to FDA clinical hold letter
Premium
The Fly
Serina Therapeutics submits complete response to FDA clinical hold letter
5M ago
Serina Therapeutics Secures $20M Convertible Note Agreement
PremiumCompany AnnouncementsSerina Therapeutics Secures $20M Convertible Note Agreement
8M ago
Serina Therapeutics Inc trading resumes
Premium
The Fly
Serina Therapeutics Inc trading resumes
8M ago
Serina Therapeutics Secures $20M for Parkinson’s Trial
Premium
Company Announcements
Serina Therapeutics Secures $20M for Parkinson’s Trial
8M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100